UBE announces Phase I clinical trial for SSAO/VAP-1 licensed exclusively to Novo Nordisk
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
The 200 bedded hospital owned & operated by Alexis
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Medway setup a state-of-the-art Heart Institute in Chennai
The product is expected to be launched in December 2023
Receives registration of Valganciclovir powder for oral solution in Germany
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
This acquisition marks Max Healthcare's entry into Lucknow
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Subscribe To Our Newsletter & Stay Updated